From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 4,848,678 shares, representing 14.76% for $15.58 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +2.72% |
|
+7.32% | -0.75% |
07-02 | Co-Diagnostics Expands Vector Control Customer Base | MT |
07-02 | Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.75% | 41.29M | |
-26.50% | 16.3B | |
+13.44% | 1.79B | |
-15.91% | 1.4B | |
+44.20% | 1.38B | |
+5.30% | 833M | |
-30.52% | 799M | |
-38.05% | 707M | |
+27.36% | 606M | |
-26.54% | 615M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.